Clinical Trial Update: Study of Sorafenib In Combination With Low-dose 5-fluorouracil/Cisplatin (FP) Intraarterial Infusion Chemotherapy [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial studying sorafenib in combination with low-dose 5-fluorouracil and cisplatin intraarterial infusion for hepatocellular carcinoma has …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• 5-Fluorouracil (5-FU)
• CISPLATIN (cisplatin)
• Sorafenib (Sorafenib)

Snippet

Sponsor: Kindai University | Conditions: Hepatocellular Carcinoma | Phase 1, Phase 2 | Status: COMPLETED